| abstract |
(57) [Summary] [Object] The present invention provides an ester of (R) (-)-carnitine and acyl- (R) (-)-carnitine with β-hydroxybutyric acid, or a pharmaceutically acceptable salt thereof, And inhibition of neuronal degeneration containing this as an active ingredient, Provided is a pharmaceutical composition for suppressing hepatic protein degradation and treating coma. [Structure] (R) (-)-carnitine and acyl- (R) (−)-Carnitine and β-hydroxybutyric acid ester, and a pharmaceutical composition containing the same as an active ingredient. |